pharmapress 0.2% ophthalmic solution is a medication that contains the active ingredient brimonidine, which is an alpha-2 adrenergic agonist. By binding to alpha-2 adrenergic receptors in the eye, it reduces the production of aqueous humor, the fluid that maintains intraocular pressure. Additionally, it increases uveoscleral outflow, which further aids in lowering intraocular pressure. The overall effect is a decrease in fluid accumulation within the eye, thereby alleviating pressure that can lead to optic nerve damage and vision loss associated with glaucoma.
Indications and Uses of pharmapress 0.2% ophthalmic solution
- Treatment of elevated intraocular pressure in patients with open-angle glaucoma
- Management of ocular hypertension
Side Effects of pharmapress 0.2% ophthalmic solution
- Dry mouth
- Burning or stinging sensation in the eye
- Fatigue
- Headache
- Redness of the eye
Storage and Handling
Store pharmapress 0.2% ophthalmic solution at room temperature, away from direct sunlight and moisture. Keep the bottle tightly closed when not in use and out of reach of children.
Patient Advice and Precautions
Patients should be advised to wash their hands before using the drops. Avoid touching the dropper tip to any surface to prevent contamination. It is advisable to blink several times after instilling the drops to ensure proper distribution. If using other eye medications, wait at least 5 to 10 minutes between applications. Consult an eye care professional if experiencing prolonged discomfort or any adverse effects.
Scientific Degree: Pharmacist
Country: Egypt
Pharmacist Hossam Mohamed Abdel Azeem is a Doctor of Pharmacy (PharmD) and a specialized medical content writer. He holds a Bachelor's degree in Clinical/General Pharmacy from Suez Canal University (Ismailia). With practical experience dating back to 2013 in community pharmacy practice and pharmaceutical consulting, he has worked with prominent establishments such as certified pharmaceutical institutions in Egypt. Dr. Hossam specializes in simplifying complex medical information, analyzing drug interactions, and clarifying medication usage for the general public, ensuring the delivery of reliable, evidence-based medical content.
Published Date: 30 April 2025
Source 1 :
Drugs Brimonidine ophthalmic
you should ask your doctor before taking this medicine